Latest news
Immutep Reports ASCO and EULAR Data, Ongoing TACTI-004 Review, and H1 CY28 Cash Runway Outlook - Quiver QuantitativeQuiver Quantitative · Thu, 30 Jul 2026 07:00:00 GMTOncology Experts Review Key ASCO 2026 Data for Daraxonrasib and Other Novel Therapies in GI Cancers - OncLiveOncLive · Wed, 29 Jul 2026 07:00:00 GMT